New Five-Year Sotyktu (deucravacitinib) Data Show Consistent Safety and Durable Response Rates in Moderate-to-Severe Plaque Psoriasis - Business Fast

Recommended For You

Starmer facing pressure to be bold with Trump in Washington visit

February 21, 2025Politics

Pep Guardiola ready to sell eight Man City stars to fund summer transfer rebuild

February 21, 2025Sports

India on track for $35 trillion economy, States & Centre in sync: Piyush Goyal

February 21, 2025Global Economy

Indonesia shares higher at close of trade; Jakarta Stock Exchange Composite up 0.08%

February 21, 2025Stockmarket

UK lenders paid car dealers cash upfront that may have led to costlier loans

February 21, 2025legal

This website uses cookies. By continuing to use this site, you accept our use of cookies.